Hmab Formulations Private Limited
About Hmab Formulations Private Limited
Data last updated:
Hmab Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2021PTC158377.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vishnu Kiran Meka and Manjula Sukapala.
Its last annual general meeting (AGM) was held on 26 December 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Plot No 102 Aishwarya Homes Sri Balajilayout Gajularamaram X Roads, Hyderabad, Telangana, India – 500055.
Company details
Contact details
Hmab Formulations Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressPlot No 102 Aishwarya Homes Sri Balajilayout Gajularamaram X Roads, Hyderabad, Telangana, India – 500055
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Hmab Formulations Private Limited
FY 2022 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2021-22 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Hmab Formulations Private Limited, buy the company report.
Board of directors of Hmab Formulations Private Limited
Hmab Formulations has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishnu Kiran Meka | Director | 16 Sep 2022 | 4 Years 1 Months | Current |
| Manjula Sukapala | Director | 30 Dec 2021 | 4 Years 9 Months | Current |
| Anusree Vallabhaneni Also directs: Plavika Bio LLP | Director | 30 Dec 2021 | 4 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Hmab Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hmab Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Hmab Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Hmab Formulations Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Vishnu Kiran Meka was appointed as Director on 16 Sep 2022.
Frequently asked questions
Hmab Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 December 2021 (5+ years old) and is registered under CIN U24299TG2021PTC158377.
Hmab Formulations has 3 current directors:
- Vishnu Kiran Meka - Director
- Manjula Sukapala - Director
- Anusree Vallabhaneni - Director
The latest financial statements of Hmab Formulations on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 26 December 2022. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Hmab Formulations is U24299TG2021PTC158377. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hmab Formulations was incorporated on 30 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
Vishnu Kiran Meka was appointed as Director on 16 Sep 2022. Anusree Vallabhaneni was appointed as Director on 30 Dec 2021. Manjula Sukapala was appointed as Director on 30 Dec 2021.
The registered office of Hmab Formulations is at Plot No 102 Aishwarya Homes Sri Balajilayout Gajularamaram X Roads, Hyderabad, Telangana, India – 500055.
Hmab Formulations operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Hmab Formulations can be reached at its registered office: Plot No 102 Aishwarya Homes Sri Balajilayout Gajularamaram X Roads, Hyderabad, Telangana, India – 500055.
Hmab Formulations is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.